1. Fda, Guidance for industry: nonclinical safety evaluation of pediatric drug products, 2006. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm079247.pdf. (Accessed January 17, 2022).
2. Ema, Guideline on the need for non-clinical testing in juvenile animals on human pharmaceuticals for paediatric indications. Ref. EMEA/CHMP/SWP/169215/2008, 2008. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003305.pdf. (Accessed January 17, 2022).
3. Mhlw Japan, Guideline on the Nonclinical Safety Study in Juvenile Animals for Pediatric Drugs and Questions and Answers Regarding Guideline on the Non-clinical Safety Study in Juvenile Animals for Pediatric Drugs, 2012. https://www.pref.kagawa.lg.jp/documents/7476/161_241015.pdf. (Accessed January 17, 2022).
4. The value of juvenile animal studies What have we learned from preclinical juvenile toxicity studies? II;Bailey;Birth Defects Res. B Dev. Reprod. Toxicol.,2011
5. Comparative organ system development: an update;Ridings;Birth Defects Res.,2018